Alvotech (ALVO) EBITDA (2021 - 2026)
Alvotech's (ALVO) quarterly EBITDA came in at -$73.4 million in Q2 2026, down 739.36% on a YoY basis from $11.5 million in Q2 2025, and down 858.93% quarter-over-quarter from $9.7 million in Q1 2026.
Analysis
Alvotech (ALVO) EBITDA (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported EBITDA for 6 consecutive years, with -$73.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA fell 739.36% year-over-year to -$73.4 million; the trailing twelve-month figure through Jun 2026 stood at -$293.0 million (down 324.96% YoY), and the FY2025 full-year result was $78.2 million, up 127.23% from the prior year.
- EBITDA fell to -$73.4 million in Q2 2026 per ALVO's latest filing, from $9.7 million in the prior quarter.
- Across five years, EBITDA topped out at $248.0 million in Q3 2024 and bottomed at -$354.9 million in Q1 2023.
- Historically, EBITDA has averaged -$103.2 million across 5 years, with a median of -$108.4 million in 2024.
- The sharpest annual moves came in 2025 and 2026: EBITDA surged 271.09% in 2025, then sank 739.36% in 2026.
- Over 5 years, EBITDA stood at -$346.4 million in 2022, then decreased by 2.43% to -$354.9 million in 2023, then soared by 45.95% to -$191.8 million in 2024, then soared by 138.63% to $74.1 million in 2025, then sank by 199.09% to -$73.4 million in 2026.
- According to Business Quant data, EBITDA over the past three periods registered -$73.4 million, $9.7 million, and $74.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.57 Bn | 38.91 Bn | 2.15 Bn | -231.00 Mn |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn | 6.30 Mn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 39.97 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 129.77 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn | 740.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -73.42 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 40.46 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 39.73 Mn |
| 9 | Fennec Pharmaceuticals | 406.25 Mn | 365.00 Mn | 17.15 Mn | 1.74 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -73.42 Mn |
| Mar 31, 2026 | 9.67 Mn |
| Dec 31, 2025 | 74.09 Mn |
| Sep 30, 2025 | -303.39 Mn |
| Jun 30, 2025 | -8.75 Mn |
| Mar 31, 2025 | 82.84 Mn |
| Dec 31, 2024 | -191.82 Mn |
| Sep 30, 2024 | 247.99 Mn |
| Jun 30, 2024 | -143.40 Mn |
| Mar 31, 2024 | -48.42 Mn |
| Dec 31, 2023 | -354.86 Mn |
| Aug 31, 2023 | -189.10 Mn |
| Jun 30, 2023 | 148.67 Mn |
| Mar 20, 2023 | -354.86 Mn |
| Dec 31, 2022 | -346.44 Mn |
| Aug 31, 2022 | -203.58 Mn |
| Jun 30, 2022 | 142.86 Mn |
| Mar 20, 2022 | -346.44 Mn |
| Dec 31, 2021 | -235.46 Mn |
| Sep 30, 2021 | -75.58 Mn |